Sbir phase II proposal titled innovative and adaptive drug delivery system for enhanced neuroprotection and repair in traumatic brain injuries from penetrating trauma or open skull fractures in low…
Active Definitive Contract Awarded Last action
- Contract number
- HT942525CE032
- Awardee
-
Altrazeal Life Sciences Inc. UEI N24WUMUHT5V9
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,300,000
Award facts
- Opportunity
-
- HQ003420RBDST Solicitation number
- Contract value 100% obligated
- $1,299,999.92 Current and potential, with all options
- Completion date 51% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Addison, TX 75001, USA
- Research
- SBIR Program Phase II Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,300,000 |
About this award
The Defense Health Agency awarded a Phase II SBIR definitive contract to Altrazeal Life Sciences Inc. on September 2, 2025, under a total small business set-aside, for development of an innovative and adaptive drug delivery system for enhanced neuroprotection and repair in traumatic brain injuries from penetrating trauma or open skull fractures in low-resource environments. The award carries a ceiling value of $1,299,999.92 on a firm-fixed-price basis.
Performance is in Addison, Texas, with an ultimate completion date of January 4, 2028.
Description
Sbir phase II proposal titled innovative and adaptive drug delivery system for enhanced neuroprotection and repair in traumatic brain injuries from penetrating trauma or open skull fractures in low resource environments
Quick answers
Who was awarded contract HT942525CE032?
HT942525CE032 was awarded to Altrazeal Life Sciences Inc. by Defense Health Agency (Department of Defense) on September 2, 2025.
How much is contract HT942525CE032 worth?
The government has obligated $1,300,000 on HT942525CE032.
Was contract HT942525CE032 competed?
The extent of competition for HT942525CE032 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award